TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free RNAZ Stock Alerts $1.02 -0.14 (-12.07%) (As of 05:45 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TransCode Therapeutics Stock Price Performance5 Day Performance+24.39%1 Month Performance+55.73%3 Month Performance+51.34%6 Month Performance-93.36%Year-To-Date Performance-84.53%1 Year Performance-99.60% Receive RNAZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. RNAZ Stock Chart for Wednesday, May, 8, 2024 RNAZ Chart by TradingView TransCode Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.81$1.16+42.38%$1.20$0.814.88 million shs$7.09 million05/06/2024$0.82$0.81-0.65%$0.88$0.801.05 million shs$4.98 million05/03/2024$0.71$0.82+15.98%$1.05$0.706.05 million shs$5.01 million05/02/2024$0.63$0.71+12.26%$0.79$0.631.86 million shs$4.32 million05/01/2024$0.61$0.63+3.74%$0.64$0.59413,056 shs$3.53 million04/30/2024$0.60$0.61+1.79%$0.62$0.56493,848 shs$3.53 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.55$0.60+8.46%$0.63$0.531.17 million shs$3.47 million04/26/2024$0.53$0.55+4.74%$0.58$0.50711,173 shs$3.20 million04/25/2024$0.44$0.53+19.35%$0.54$0.441.24 million shs$3.05 million04/24/2024$0.46$0.44-4.35%$0.47$0.4291,180 shs$2.56 million04/23/2024$0.46$0.46+0.20%$0.47$0.45101,044 shs$2.67 million04/22/2024$0.49$0.46-5.36%$0.49$0.42278,389 shs$2.67 million04/19/2024$0.50$0.49-3.39%$0.50$0.48112,982 shs$2.82 million04/18/2024$0.50$0.50+0.10%$0.52$0.48406,090 shs$2.92 million04/17/2024$0.51$0.50-0.69%$0.54$0.48309,841 shs$2.91 million04/16/2024$0.54$0.51-5.84%$0.53$0.47423,662 shs$2.93 million04/15/2024$0.62$0.54-13.68%$0.66$0.503.53 million shs$3.12 million04/12/2024$0.64$0.62-2.81%$0.64$0.61114,088 shs$391,000.0004/11/2024$0.64$0.64+0.51%$0.65$0.60115,848 shs$403,000.0004/10/2024$0.64$0.64-0.66%$0.67$0.6471,733 shs$401,000.0004/09/2024$0.66$0.64-2.26%$0.66$0.6482,825 shs$403,000.0004/08/2024$0.64$0.66+2.34%$0.66$0.6461,613 shs$411,000.0004/05/2024$0.68$0.64-5.87%$0.67$0.6492,339 shs$403,000.0004/04/2024$0.65$0.68+4.60%$0.69$0.6556,460 shs$428,000.0004/03/2024$0.68$0.65-4.71%$0.69$0.65171,070 shs$410,000.0004/02/2024$0.69$0.68-1.43%$0.70$0.66233,141 shs$430,000.0004/01/2024$0.68$0.69+1.32%$0.71$0.66163,778 shs$436,000.0003/29/2024$0.68$0.68+0.98%$0.68$0.62248,176 shs$430,000.0003/28/2024$0.68$0.68-0.37%$0.68$0.62248,159 shs$426,000.0003/27/2024$0.66$0.68+2.88%$0.68$0.63157,733 shs$428,000.0003/26/2024$0.68$0.66-2.66%$0.68$0.6388,825 shs$416,000.0003/25/2024$0.67$0.68+1.74%$0.69$0.6682,917 shs$427,000.0003/22/2024$0.68$0.67-2.30%$0.68$0.6573,626 shs$420,000.0003/21/2024$0.70$0.68-2.57%$0.70$0.62170,343 shs$430,000.0003/20/2024$0.68$0.70+2.76%$0.72$0.67313,452 shs$441,000.0003/19/2024$0.68$0.68+0.71%$0.70$0.65135,207 shs$427,000.0003/18/2024$0.69$0.68-2.11%$0.70$0.61150,539 shs$426,000.0003/15/2024$0.69$0.69+0.16%$0.70$0.67140,245 shs$435,000.0003/14/2024$0.65$0.69+6.14%$0.70$0.65236,692 shs$433,000.0003/13/2024$0.60$0.65+9.24%$0.66$0.60218,980 shs$410,000.00Could this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$0.64$0.60-6.87%$0.63$0.57532,380 shs$375,000.0003/11/2024$0.70$0.64-8.60%$0.72$0.631.33 million shs$403,000.0003/08/2024$0.73$0.69-5.34%$0.73$0.68347,845 shs$435,000.0003/07/2024$0.70$0.73+4.29%$0.73$0.70303,730 shs$460,000.0003/06/2024$0.69$0.70+1.87%$0.72$0.68322,636 shs$441,000.0003/05/2024$0.70$0.69-1.84%$0.71$0.68133,540 shs$433,000.0003/04/2024$0.72$0.70-2.78%$0.73$0.70190,661 shs$441,000.0003/01/2024$0.70$0.72+2.19%$0.74$0.70312,119 shs$454,000.0002/29/2024$0.70$0.70+1.22%$0.71$0.68378,976 shs$442,000.0002/28/2024$0.71$0.70-1.81%$0.71$0.69202,182 shs$439,000.0002/27/2024$0.71$0.71-0.18%$0.72$0.69430,571 shs$447,000.0002/26/2024$0.69$0.71+3.30%$0.74$0.69861,032 shs$447,000.0002/23/2024$0.73$0.69-4.96%$0.72$0.67219,143 shs$435,000.0002/22/2024$0.67$0.73+8.36%$0.73$0.65447,434 shs$457,000.0002/21/2024$0.68$0.67-1.33%$0.69$0.64260,356 shs$422,000.0002/20/2024$0.68$0.68$0.69$0.66499,771 shs$428,000.0002/19/2024$0.68$0.68$0.69$0.63168,400 shs$426,000.0002/16/2024$0.66$0.68+2.88%$0.69$0.63159,092 shs$428,000.0002/15/2024$0.70$0.66-5.70%$0.72$0.61695,046 shs$414,000.0002/14/2024$0.70$0.70$0.74$0.65538,793 shs$441,000.0002/13/2024$0.71$0.70-1.14%$0.70$0.65362,014 shs$441,000.0002/12/2024$0.70$0.71+1.14%$0.76$0.68709,850 shs$446,000.0002/09/2024$0.67$0.70+3.86%$0.74$0.64789,602 shs$441,000.0002/08/2024$0.60$0.67+12.30%$0.69$0.61544,812 shs$425,000.0002/07/2024$0.62$0.60-2.88%$0.64$0.57428,313 shs$378,000.00 Related Companies: PhaseBio Pharmaceuticals Stock Chart Atreca Stock Chart Revelation Biosciences Stock Chart Seelos Therapeutics Stock Chart GeoVax Labs Stock Chart Phio Pharmaceuticals Stock Chart Biophytis Stock Chart Virpax Pharmaceuticals Stock Chart Evoke Pharma Stock Chart Agile Therapeutics Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.